Loading…
Wave Life Sciences Ltd. is projected to rise to $6.55 by 2027, a +19% move from its current price of $5.51. WVE is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 2 | $5.39 | $5.51 | $5.63 | +0.01% |
| Aug 3 | $5.34 | $5.51 | $5.69 | +0.01% |
| Aug 4 | $5.30 | $5.51 | $5.73 | +0.02% |
| Aug 5 | $5.27 | $5.51 | $5.76 | +0.02% |
| Aug 6 | $5.24 | $5.51 | $5.79 | +0.03% |
| Aug 7 | $5.22 | $5.51 | $5.82 | +0.04% |
| Aug 8 | $5.20 | $5.51 | $5.85 | +0.04% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $5.20 | $5.51 | $5.85 | +0.04% |
| Week 2 | $5.07 | $5.51 | $5.99 | +0.09% |
| Week 3 | $4.98 | $5.52 | $6.11 | +0.13% |
| Week 4 | $4.91 | $5.52 | $6.21 | +0.17% |
| Week 5 | $4.84 | $5.52 | $6.30 | +0.21% |
| Week 6 | $4.78 | $5.52 | $6.38 | +0.26% |
| Week 7 | $4.73 | $5.53 | $6.46 | +0.30% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Wave Life Sciences Ltd. is a clinical-stage biotechnology company that designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform. The medicines platform combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders.
Wave Life Sciences Ltd. (WVE) is a healthcare stock with a current price of $5.67 and a market capitalization of $1.09B, ranking 2446.
A major floor 10.5% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
The nearest ceiling, 15.8% above — a clean break opens room to run.
A major ceiling 123.2% above — clearing it would confirm fresh momentum.
Key WVE support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of WVE market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $5.78 | Sell | $5.71 | Sell |
| MA 10 | $5.77 | Sell | $5.78 | Sell |
| MA 20 | $5.94 | Sell | $5.86 | Sell |
| MA 50 | $5.98 | Sell | $6.25 | Sell |
| MA 100 | $7.19 | Sell | $7.28 | Sell |
| MA 200 | $9.60 | Sell | $8.34 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 37.33 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -140.04 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -6.77 | Sell |
| Bollinger %B (20,2) | 0.06 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.18 | Sell |
| Awesome (5,34) | -0.16 | Sell |
| Ultimate (7,14,28) | 33.54 | Neutral |
| Momentum (10) | -0.31 | Sell |
| Aroon Osc (25) | -72.00 | Sell |
| Hull MA (9) | 5.72 | Sell |
| ADX (14) | 13.18 | Neutral |
| ATR (14) | 0.12 | Info |
The near-term technical picture is bearish, with RSI(14) at 40. The stock trades around the 50-day moving average at $6.23 and below the 200-day moving average at $9.69, suggesting a weak intermediate trend. Support sits at $5.66 and resistance at $6.38, placing the current price within the tighter end of a recent range that spanned from $4.74 to $6.78 over the last 30 days.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $5.51 | $5.51 | $6.96 | 0% | Neutral | |
| $5.31 | $6.55 | $8.48 | +19% | Neutral | |
| $5.60 | $7.07 | $9.45 | +28% | Bullish | |
| $6.02 | $7.74 | $10.60 | +40% | Bullish | |
| $5.90 | $7.71 | $10.78 | +40% | Bullish | |
| $5.92 | $7.85 | $11.18 | +43% | Bullish | |
| $6.34 | $8.52 | $12.33 | +55% | Bullish | |
| $6.30 | $8.58 | $12.61 | +56% | Bullish | |
| $7.20 | $9.92 | $14.78 | +80% | Bullish | |
| $8.21 | $11.44 | $17.26 | +108% | Bullish | |
| $9.38 | $13.77 | $21.91 | +150% | Bullish | |
| $16.62 | $26.61 | $45.81 | +383% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $5.51 | $5.51 | $6.66 | +0.00% |
| September 2026 | $4.81 | $5.66 | $6.83 | +2.81% |
| October 2026 | $4.68 | $5.54 | $6.74 | -2.19% |
| November 2026 | $4.61 | $5.48 | $6.72 | -1.05% |
| December 2026 | $4.72 | $5.64 | $6.96 | +2.85% |
Click any year to see its month-by-month WVE forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect WVE to range from $5.51 to $6.96 through 2026. The $5.51 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The WVE price prediction for 2027 points to an average of $6.55 (low $5.31, high $8.48) — a potential gain of +19% on today's $5.51. Price action looks broadly range-bound.
In 2028, WVE is projected to trade between $5.60 and $9.45, averaging $7.07 — a potential gain of +28% from today's $5.51. That is up +8% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Wave Life Sciences Ltd.'s 2029 outlook centres on $7.74, within a $6.02 to $10.60 range. That is up +10% on the projected 2028 average. That marks a +40% change versus current levels. Momentum favours further upside here.
By 2030, WVE could reach as high as $10.78, with a base case around $7.71 and support toward $5.90 — roughly +40% from $5.51. Buyers look set to stay in control over this stretch.
Expect WVE to range from $5.92 to $11.18 through 2031. The $7.85 average target implies a +43% move from current prices. That is up +2% on the projected 2030 average. Momentum favours further upside here.
The WVE price prediction for 2032 points to an average of $8.52 (low $6.34, high $12.33) — a potential gain of +55% on today's $5.51. Buyers look set to stay in control over this stretch.
In 2033, WVE is projected to trade between $6.30 and $12.61, averaging $8.58 — a potential gain of +56% from today's $5.51. That is up +1% on the projected 2032 average. Momentum favours further upside here.
Wave Life Sciences Ltd.'s 2034 outlook centres on $9.92, within a $7.20 to $14.78 range. That is up +16% on the projected 2033 average. That marks a +80% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, WVE could reach as high as $17.26, with a base case around $11.44 and support toward $8.21 — roughly +108% from $5.51. Momentum favours further upside here.
Expect WVE to range from $9.38 to $21.91 through 2040. The $13.77 average target implies a +150% move from current prices. That is up +20% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The WVE price prediction for 2050 points to an average of $26.61 (low $16.62, high $45.81) — a potential gain of +383% on today's $5.51. Momentum favours further upside here.
Investing $1,000 in WVE today (≈ 181.488203 WVE) could be worth
$4,829.86
+$3,829.86 (+383%) by 2050 · US Dollar
Based on the average projected WVE price of $26.61 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in WVEwould be worth at today's price.
$1,000 invested in WVE on Jul 31, 2025 (≈ 123.456784 WVE) would be worth
$680.25
-$319.75 (-32.0%) today · 0.68× · US Dollar
Based on a WVE entry price of $8.1 vs. today's $5.51.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $5.81 | $948.36 | -5.2% |
| 1 month ago | $5.84 | $943.49 | -5.7% |
| 3 months ago | $7.32 | $752.73 | -24.7% |
| 6 months ago | $13.43 | $410.28 | -59.0% |
| 1 year ago | $8.1 | $680.25 | -32.0% |
| All time (5.0y) ago | $5.61 | $982.17 | -1.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our WVE forecast.
Our base-case forecast reaches $11.00 around 2035.
Implied market cap at $11.00: $2.17B
Longer-term forecasts show a bullish trajectory across the late 2020s into the 2030s and beyond. For 2026 the min/avg/max are $5.66/$5.67/$7.33 with an ROI of 0 and a neutral sentiment. From 2027 onward, the average forecast rises from $6.79 (2027) to $7.39 (2028) and $8.09 (2029), then to $7.86 (2030), $8.03 (2031), $8.68 (2032), and $8.44 (2033).
The horizon continues to 2040 with an average of $13.92 and an ROI of 145.5, and culminates in 2050 with an average of $26.99 and an ROI of 376.1, with a max forecast of $49.73. These figures point to a sustained bullish outlook, though they are estimates and not guarantees. Wave Life Sciences’ longer-term forecast indicates continued upside potential across the 2030s to 2050, accompanied by inherent investment risks.
Tap a question to reveal the answer.
2030 – min $5.83, avg $7.86, max $11.40; ROI 38.6; sentiment BULLISH.
The long-term forecast is bullish with averages rising to $26.99 by 2050 and ROI up to 376.1, but near-term 2026 is neutral and risk remains. These are estimates, not guarantees.
Yes. The forecast shows 2034–2035 ranges approaching the mid-teens and 2040–2050 ranges exceeding $20, with a 2050 max of $49.73.
Current price is $5.67 and market cap is $1.09B.
Bearish sentiment with RSI 40; SMA50 at $6.23 and SMA200 at $9.69. Support is at $5.66 and resistance at $6.38. The 30-day range is $4.74 to $6.78.
Wave Life Sciences Ltd. Community Discussion
0Share your Wave Life Sciences Ltd. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.